본문으로 건너뛰기
← 뒤로

A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition.

4/5 보강
Nature 📖 저널 OA 64.1% 2021: 8/20 OA 2022: 7/17 OA 2023: 20/35 OA 2024: 32/49 OA 2025: 113/162 OA 2026: 113/151 OA 2021~2026 2018 Vol.562(7727) p. 429-433 피인용 3회 cited 139 RCR 3.03 Hedgehog Signaling Pathway Studies
TL;DR Treatment of BCC with both vismodegib and a Wnt pathway inhibitor reduced the residual tumour burden and enhanced differentiation and identified a resistance mechanism in which tumour cells evade treatment by adopting an alternative identity that does not rely on the original oncogenic driver for survival.
Retraction 확인
출처
PubMed DOI OpenAlex Semantic 마지막 보강 2026-05-07
📑 코퍼스 인용 관계 · 인용됨 3
📑 인용한 논문 (3) ▾
연도별 인용 (2018–2025) · 합계 139
OpenAlex 토픽 · Hedgehog Signaling Pathway Studies Cancer and Skin Lesions Tumors and Oncological Cases

Biehs B, Dijkgraaf GJP, Piskol R, Alicke B, Boumahdi S, Peale F

관련 도메인

📝 환자 설명용 한 줄

Treatment of BCC with both vismodegib and a Wnt pathway inhibitor reduced the residual tumour burden and enhanced differentiation and identified a resistance mechanism in which tumour cells evade trea

이 논문을 인용하기

↓ .bib ↓ .ris
APA Brian Biehs, Gerrit J.P. Dijkgraaf, et al. (2018). A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition.. Nature, 562(7727), 429-433. https://doi.org/10.1038/s41586-018-0596-y
MLA Brian Biehs, et al.. "A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition.." Nature, vol. 562, no. 7727, 2018, pp. 429-433.
PMID 30297801 ↗

Abstract

Despite the efficacy of Hedgehog pathway inhibitors in the treatment of basal cell carcinoma (BCC), residual disease persists in some patients and may contribute to relapse when treatment is discontinued. Here, to study the effect of the Smoothened inhibitor vismodegib on tumour clearance, we have used a Ptch1-Trp53 mouse model of BCC and found that mice treated with vismodegib harbour quiescent residual tumours that regrow upon cessation of treatment. Profiling experiments revealed that residual BCCs initiate a transcriptional program that closely resembles that of stem cells of the interfollicular epidermis and isthmus, whereas untreated BCCs are more similar to the hair follicle bulge. This cell identity switch was enabled by a mostly permissive chromatin state accompanied by rapid Wnt pathway activation and reprogramming of super enhancers to drive activation of key transcription factors involved in cellular identity. Accordingly, treatment of BCC with both vismodegib and a Wnt pathway inhibitor reduced the residual tumour burden and enhanced differentiation. Our study identifies a resistance mechanism in which tumour cells evade treatment by adopting an alternative identity that does not rely on the original oncogenic driver for survival.

추출된 의학 개체 (NER)

전체 NER 표 보기
유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 hair follicle 모낭 dict 1
해부 hair follicle 모낭 dict 1
해부 hair follicle 모낭 dict 1

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

인용 관계

그래프 OA 노드: 3/3 (100%) · 참조 0편 · 후속 3편

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

📖 비슷한 OA 논문 — 같은 카테고리, 무료 전문 가능